The Hindu Business Line : New drug from Panacea

NEW DELHI: Panacea Biotec has introduced Odipep, an innovative drug delivery system-based therapy for management of gastroesophageal reflux disease (GERD), caused by backflow of acid from the stomach into the swallowing tube or oesophagus, and non ulcer dyspepsia (NUD), which causes abdominal pain.

Odipep, a prescription drug, inhibits gastric acid secretion, relieves nausea and vomiting.

In a statement, Mr Rajesh Jain, Joint Managing Director, said: "Odipep ensures immediate and sustained relief from GERD and has a potential to revolutionise the Rs 42.33-crore pantaprazole and domperidone fixed dose combination market, which is growing at 112 per cent."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Food processing industry still divided on allowing FDI in retail sector

Bollywood on mobiles

Bharat Patel re-elected Chairman of ISA

Corporate picture

Emami ropes in Shah Rukh as new brand ambassador

Ranbaxy enters into in-licence pact with Lupin for TB drug — Drug to be marketed in West, North Africa

VIP unveils new brand identity — To step up adspend, retail presence

A lab to detect spurious medicines

New Executive V-P at ESPN

Amrish Sethi appointed as Creative Director of Turner International

H-P tops in x-86 server market

New drug from Panacea

Michale Mercantile fuel saver